The molecular tests performed were those standardized for B-ALL diagnosis including: ETV6-RUNX1, TCF3-PBX1, BCR-ABL1, P2RY8-CRLF2 and KMT2A-AFF1 for 220 samples. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.